The LGBTQ Health Equity Series is a comprehensive eight-module certificate program designed to strengthen healthcare professionals’ knowledge, skills, and practices in providing affirming, equitable, and culturally responsive HIV prevention and care to LGBTQ individuals. Across the series, participants will explore the social, structural, behavioral, and clinical factors shaping HIV disparities among LGBTQ populations, and gain practical strategies for delivering patient-centered care across diverse communities and care settings.
The LGBTQ Health Equity Series is a comprehensive eight-module certificate program designed to strengthen healthcare professionals’ knowledge, skills, and practices in providing affirming, equitable, and culturally responsive HIV prevention and care to LGBTQ individuals. Across the series, participants will explore the social, structural, behavioral, and clinical factors shaping HIV disparities among LGBTQ populations, and gain practical strategies for delivering patient-centered care across diverse communities and care settings.
The LGBTQ Health Equity Series is a comprehensive eight-module certificate program designed to strengthen healthcare professionals’ knowledge, skills, and practices in providing affirming, equitable, and culturally responsive HIV prevention and care to LGBTQ individuals. Across the series, participants will explore the social, structural, behavioral, and clinical factors shaping HIV disparities among LGBTQ populations, and gain practical strategies for delivering patient-centered care across diverse communities and care settings.
As HIV prevention evolves, long-acting injectable options like lenacapavir are emerging as promising tools to expand access and adherence. Effective implementation of new interventions calls for thoughtful planning across key areas, including operations, staffing, finance, and patient access.
This webinar covers patient navigation touchpoints along the PrEP continuum for injectable lenacapavir, patient education strategies, expanding the capacity of PrEP navigation staff to implement injectable PrEP, and future opportunities for expanded implementation in mobile health settings.
In the first webinar of the series, faculty – including principal investigators from the PURPOSE trials – review clinical data and delve into opportunities and challenges for the real-world implementation of lenacapavir as PrEP.
This webinar covers medication administration, managing side effects, potential drug interactions, and transitioning patients on or off lenacapavir as PrEP.